E-cigarettes didn’t help smokers quit, study says

the study, Published in the journal BMJ on MondayAnalyzed the latest 2017-2019 data from the Tobacco and Health Survey Census, which tracked American tobacco use over time.
“This is the first time we’ve found e-cigarettes to be less popular than FDA-approved medicines, including the use of medicines, patches, gums and lozenges,” he said. John P. EarringsDirector of Population Science, Moors Cancer Center, University of California, San Diego.

“E-cigarettes were also associated with a low success rate of smoking cessation during that period,” said Pierce, an emeritus professor of family medicine and public health. In fact, a new study found that nearly 60% of recent ex-smokers who used e-cigarettes daily resumed smoking by 2019.

“There is no evidence that the use of e-cigarettes is an effective smoking cessation aid,” Pierce said.

Studies have found that using e-cigarettes to prevent the recurrence of smoking does not work well.
3-month randomized trial in the UK, Published in 2019The e-cigarettes found, along with behavioral intervention, helped smokers quit smoking. In the guidance released in the second half of 2021, National Institute for Health and Care Technology Evaluation We have decided to encourage smokers to use e-cigarettes to help them quit smoking.
but, Observational study In the United States, which is studying smoking in a real-world environment, that is not known to be true, Pierce said. A 2021 study According to his team, those who switched to e-cigs or other tobacco products and quit smoking between 2013 and 2016 can resume smoking compared to those who quit smoking all tobacco products. It turned out that the sex was 8.5% higher.

Uptick for use by teens

Proponents of e-cigarettes as a smoking cessation tool say higher nicotine versions should help cigarette smokers According to Pierce, quitting smoking because you smoke less often than you smoke the entire cigarette.

More than 2 million teens in the United States use e-cigarettes, a quarter of which are used daily. CDC and FDA

“In 2017, cigarette sales increased by 40%,” he said, with the majority of the market share being dominated by new brands of e-cigarettes with very high nicotine levels.

“We wanted to see these new high nicotine versions and see if there was evidence that helped people quit because the previous ones didn’t.”

According to Pierce, instead of increased use by smokers, the use of e-cigarettes as a smoking cessation aid has decreased by 25% over two years.

Did you have a high octane e-cigarette? Would you like to use them to help those who quit smoking?

“We can’t study the effectiveness of these high nicotine e-cigarettes because they haven’t been used by smokers for most of the two years,” Pierce said. He added that there was a slight increase in 2019 and should be analyzed when the next PATH data is released.

If smokers weren’t driving sales growth between 2017 and 2019, who would they be?

More teens were using Ark during that period, according to data collected by US Food and Drug Administration..Along September 2018At the time, FDA Commissioner Dr. Scott Gottlieb called the use of teenage e-cigarettes “fashionable.”
US FDA approves Vuse e-cigarette, the first arc certification
A previous study by Pierce and his team found that e-cigarettes could act as a gateway drug for many teens. Young people aged 12 to 24 who used e-cigarettes were three times more likely to become daily smokers in the future. 2021 study found.
Vaping, in addition to its association with later smoking Also linked by teens Psychological problems, Headache, stomachache and serious addiction to nicotine. In 2019, teens began to die of lung damage. Lung damage was later associated with chemicals in vapor-breathing liquids containing vitamin E acetate. According to the American Lung Association..

The FDA has not commented on specific studies to CNN, but “as part of the evidence to support our mission to better understand specific issues and protect public health. I’m evaluating it. “

“The FDA is reviewing the findings of this paper,” FDA spokesman Allison Hunt said in an email.

Previous articleCOVID-19 Statistics | Feb. 7, 2022 | Lost Coast Outpost
Next article100,000 U.S. Deaths Due To Diabetes In 2021, Second Year In A Row


Please enter your comment!
Please enter your name here